Segall Bryant & Hamill’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,450
| Closed | -$957K | – | 564 |
|
|
2023
Q2 | $957K | Buy |
7,450
+270
| +4% | +$34.7K | 0.01% | 489 |
|
|
2023
Q1 | $834K | Sell |
7,180
-300
| -4% | -$34.8K | 0.01% | 510 |
|
|
2022
Q4 | $847K | Sell |
7,480
-300
| -4% | -$34K | 0.01% | 512 |
|
|
2022
Q3 | $627K | Sell |
7,780
-840
| -10% | -$67.7K | 0.01% | 544 |
|
|
2022
Q2 | $643K | Sell |
8,620
-160
| -2% | -$11.9K | 0.01% | 548 |
|
|
2022
Q1 | $1.12M | Hold |
8,780
| – | – | 0.01% | 502 |
|
|
2021
Q4 | $1.18M | Hold |
8,780
| – | – | 0.01% | 443 |
|
|
2021
Q3 | $1.2M | Hold |
8,780
| – | – | 0.01% | 507 |
|
|
2021
Q2 | $936K | Sell |
8,780
-99,328
| -92% | -$10.6M | 0.01% | 529 |
|
|
2021
Q1 | $9.71M | Buy |
108,108
+99,328
| +1,131% | +$8.92M | 0.1% | 223 |
|
|
2020
Q4 | $811K | Buy |
8,780
+640
| +8% | +$59.1K | 0.01% | 500 |
|
|
2020
Q3 | $839K | Buy |
8,140
+940
| +13% | +$96.9K | 0.01% | 478 |
|
|
2020
Q2 | $730K | Hold |
7,200
| – | – | 0.01% | 507 |
|
|
2020
Q1 | $485K | Hold |
7,200
| – | – | 0.01% | 598 |
|
|
2019
Q4 | $394K | Sell |
7,200
-1,880
| -21% | -$103K | 0.01% | 690 |
|
|
2019
Q3 | $339K | Hold |
9,080
| – | – | 0.01% | 713 |
|
|
2019
Q2 | $340K | Buy |
+9,080
| New | +$340K | 0.01% | 722 |
|